Long-term follow up of patients treated with a DNA vaccine (pTVG-hp) for PSA-recurrent prostate cancer

Authors: Tommaso P. Tonelli, Jens C. Eickhoff, Laura E. Johnson, Glenn Liu, Douglas G. McNeel

Source: Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)

Subject Terms: DNA vaccine, prostate cancer, prostatic acid phosphatase, long-term follow up, survival, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/f543448366ba4f7f81225df4f3929ccd

An Experimental Test of Defenses Against Avian Brood Parasitism in a Recent Host

Authors: Virginia E. Abernathy, Laura E. Johnson, Naomi E. Langmore

Source: Frontiers in Ecology and Evolution, Vol 9 (2021)

Subject Terms: Anthochaera carunculata, avian brood parasitism, egg ejection, Eudynamys orientalis, host defenses, mobbing, Evolution, QH359-425, Ecology, QH540-549.5

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fevo.2021.651733/full; https://doaj.org/toc/2296-701X

Access URL: https://doaj.org/article/54365361c0184b0a9f90cac03ddc6e38

Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine

Authors: Ellen Wargowski, Laura E. Johnson, Jens C. Eickhoff, Lauren Delmastro, Mary Jane Staab, Glenn Liu, Douglas G. McNeel

Source: Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-12 (2018)

Subject Terms: Sipuleucel-T, DNA vaccine, Prostate cancer, Prostatic acid phosphatase, Immune monitoring, Clinical trial, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-018-0333-y; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/af87872586dd4df4a01fa1683e476315

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination

Authors: Laura E. Johnson, Brian M. Olson, Douglas G. McNeel

Source: Journal for ImmunoTherapy of Cancer, Vol 5, Iss 1, Pp 1-11 (2017)

Subject Terms: Biomarker, DNA vaccine, Prostatic acid phosphatase, Prostate cancer, Interleukin 10, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s40425-017-0260-3; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/0c24ba68e7b7499d86b447cad96998b0

Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and Listeria vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming

Authors: Laura E. Johnson, Dirk Brockstedt, Meredith Leong, Peter Lauer, Erin Theisen, John-Demian Sauer, Douglas G. McNeel

Source: OncoImmunology, Vol 7, Iss 8 (2018)

Subject Terms: dna vaccine, heterologous prime-boost, listeria monocytogenes, prostatic acid phosphatase, Immunologic diseases. Allergy, RC581-607, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2162-402X

Access URL: https://doaj.org/article/4e7a46e148df47f2bda3f7e2f8cf6780

Two Case Reports of Neuroinvasive West Nile Virus Infection in the Critical Care Unit

Authors: Edgardo M. Flores Anticona, Hadeel Zainah, Daniel R. Ouellette, Laura E. Johnson

Source: Case Reports in Infectious Diseases, Vol 2012 (2012)

Subject Terms: Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: https://doaj.org/toc/2090-6625; https://doaj.org/toc/2090-6633

Access URL: https://doaj.org/article/27905216b8b9407b94453ac6d3ec97a2

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with castration-sensitive non-metastatic (M0) prostate cancer

Authors: Douglas G McNeel, Glenn Liu, Ellen Wargowski, Hamid Emamekhoo, Jens C Eickhoff, Laura E Johnson, Christos E Kyriakopoulos, Tommaso P Tonelli

Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 12 (2023)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/11/12/e008067.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/2f642e066f094a72bc45cb6a957b74fd

Phase 2 trial of T-cell activation using MVI-816 and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC)

Authors: Douglas G McNeel, Glenn Liu, Joshua M Lang, Ellen Wargowski, Hamid Emamekhoo, Mary Jane Brennan, Jens C Eickhoff, Laura E Johnson, Christos E Kyriakopoulos

Source: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 3 (2022)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/10/3/e004198.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/83dffdc4eece4620a9c1a0e189a455e3

Trends of vaccine-preventable diseases in Afghanistan from the Disease Early Warning System, 2009-2015.

Authors: Abram L Wagner, Mohammad Y Mubarak, Laura E Johnson, Julia M Porth, Jenna E Yousif, Matthew L Boulton

Source: PLoS ONE, Vol 12, Iss 6, p e0178677 (2017)

Subject Terms: Medicine, Science

File Description: electronic resource

Relation: http://europepmc.org/articles/PMC5453561?pdf=render; https://doaj.org/toc/1932-6203

Access URL: https://doaj.org/article/b443321a619c46698f227ef2cbaddc7a